Ian Mortimer - Net Worth and Insider Trading
Ian Mortimer Net Worth
The estimated net worth of Ian Mortimer is at least $2 Million dollars as of 2025-04-28. Ian Mortimer is the PRESIDENT & CEO of Xenon Pharmaceuticals Inc and owns about 45,602 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $2 Million. Details can be seen in Ian Mortimer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ian Mortimer has not made any transactions after 2025-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ian Mortimer
Ian Mortimer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ian Mortimer owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Ian Mortimer’s form 4 insider trades.
Insider Ownership Summary of Ian Mortimer
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2025-01-27 | director & PRESIDENT & CEO |
Ian Mortimer Latest Holdings Summary
Ian Mortimer currently owns a total of 1 stock. Ian Mortimer owns 45,602 shares of Xenon Pharmaceuticals Inc (XENE) as of January 27, 2025, with a value of $2 Million.
Latest Holdings of Ian Mortimer
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2025-01-27 | 45,602 | 37.98 | 1,731,964 |
Holding Weightings of Ian Mortimer
Ian Mortimer Form 4 Trading Tracker
According to the SEC Form 4 filings, Ian Mortimer has made a total of 2 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 55,000 shares on January 27, 2025, which brought Ian Mortimer around $2 Million.
Insider Trading History of Ian Mortimer
- 1
Ian Mortimer Trading Performance
GuruFocus tracks the stock performance after each of Ian Mortimer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ian Mortimer is 6.69%. GuruFocus also compares Ian Mortimer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ian Mortimer within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ian Mortimer's insider trading performs compared to the benchmark.
Performance of Ian Mortimer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.79 | | | | | |
| Relative Return to S&P 500(%) | 9.94 | | | | | |
Ian Mortimer Ownership Network
Ownership Network List of Ian Mortimer
Ownership Network Relation of Ian Mortimer
Ian Mortimer Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Ian Mortimer is the director & PRESIDENT & CEO of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include Chief Financial Officer Sherry Aulin , SVP Bus. & Corp. Development Sherrington Robin , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Ian Mortimer made 1 insider transaction in Xenon Pharmaceuticals Inc (XENE) with a net sale of 55,000. Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 31,467 shares made by Gary Patou , a net sale of 18,709 shares made by Sherry Aulin , and a net sale of 13,000 shares made by Steven Gannon .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 127,405 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 127,405 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Ian Mortimer Mailing Address
Above is the net worth, insider trading, and ownership report for Ian Mortimer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ian Mortimer's mailing address is: Burnaby A1 V5g4w8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
